Mayer, C., Bergholdt, R., Cucak, H., Rolin, B. C., Sams, A., & Rosendahl, A. (2015). Neutralizing Anti-IL20 Antibody Treatment Significantly Modulates Low Grade Inflammation without Affecting HbA1c in Type 2 Diabetic db/db Mice. PLoS One.

Mayer, Christopher, Regine Bergholdt, Helena Cucak, Bidda Charlotte Rolin, Anette Sams, e Alexander Rosendahl. "Neutralizing Anti-IL20 Antibody Treatment Significantly Modulates Low Grade Inflammation Without Affecting HbA1c in Type 2 Diabetic Db/db Mice." PLoS One 2015.

Mayer, Christopher, et al. "Neutralizing Anti-IL20 Antibody Treatment Significantly Modulates Low Grade Inflammation Without Affecting HbA1c in Type 2 Diabetic Db/db Mice." PLoS One 2015.